# Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)

> **NCT03325894** · PHASE3 · TERMINATED · sponsor: **Shire** · enrollment: 141 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder (ADHD)

## Interventions

- **DRUG:** SHP465

## Key facts

- **NCT ID:** NCT03325894
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-01-02
- **Primary completion:** 2019-01-19
- **Final completion:** 2019-01-19
- **Target enrollment:** 141 (ACTUAL)
- **Why stopped:** The study was stopped due to efficacy reasons.
- **Last updated:** 2021-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03325894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03325894, "Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03325894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*